Diana Vilar‐compte - Infectious Diseases

Author Information

Diana Vilar-Compte is affiliated with the Epidemiología Hospitalaria, Departamento de Infectología at the Instituto Nacional de Cancerología, located in Mexico City, Mexico. Her research primarily focuses on infectious diseases, particularly in the context of oncology and public health. Through her work, she has contributed significantly to understanding the implications of infectious agents in cancer patients and the broader healthcare setting.

Research Contributions

Diana Vilar-Compte has made substantial contributions to the field of infectious diseases, with a specific focus on the intersection of oncology and infectious agents. Her recent works include studies on the prognostic significance of human papillomavirus DNA in oral squamous cell carcinoma, risk factors and outcomes of Clostridioides difficile infections in cancer patients, and the impact of COVID-19 on oncologic patients and healthcare systems in Mexico. Her research is crucial in improving the clinical management and outcomes of cancer patients facing infectious challenges, particularly in resource-limited settings.

Aliases

Diana Vilar-Compte has been published under several variations of her name, including D Vilar-compte, D. Vilar-compte, and Diana Vilar–compte. These aliases may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	1800
h-index	23
Number of Papers	114

Publications:

Prognostic importance of DNA from human papillomavirus in patients with oral squamous cell carcinoma

DOI: 10.4317/medoral.25092

Year: 2022

Risk factors and clinical outcomes for Clostridioides difficile infections in a case control study at a large cancer referral center in Mexico.

DOI: 10.1016/j.ajic.2022.02.011

Year: 2022

Clinical characteristics and outcomes in a cohort of oncologic patients with COVID‐19 during the first year of the pandemic in Mexico

DOI: 10.1002/cam4.4582

Year: 2022

295. SARS-CoV-2 Infection in a Referral Cancer Center in Mexico City During the First Year of the COVID-19 Pandemic

DOI: 10.1093/ofid/ofab466.497

Year: 2021

Point Prevalence Survey of Antimicrobial Use in Four Tertiary Care Hospitals in Mexico

DOI: 10.2147/IDR.S327721

Year: 2021

Prognostic factors in cancer patients infected with SARS-CoV-2: a Latin American country results

DOI: 10.1177/20406223211047755

Year: 2021

Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study

DOI: 10.1016/j.jtcvs.2021.03.091

Year: 2021

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

DOI: 10.1016/S1470-2045(21)00493-9

Year: 2021

Development of an alternative saliva test for diagnosis of SARS-CoV-2 using TRIzol: Adapting to countries with lower incomes looking for a large-scale detection program

DOI: 10.1371/journal.pone.0255807

Year: 2021

Factors associated with influenza vaccination acceptance in Mexican healthcare workers: A multicenter cross-sectional study.

DOI: 10.1016/j.ypmed.2021.106560

Year: 2021

How is Parasite DNA Important in Infectious Diseases?

What Role Do International Organizations Play?

Why is One Health Important in Infectious Diseases?

Is There a Vaccine for Ebola?

What is Lipid Metabolism?

Why is Immune System Stimulation Important?

What Role Does Technology Play in Personalized Medicine?

What are Isoprenoids?

How Do Fungi Infect Hosts?

What are Pediatric Infectious Diseases?

Partnered Content Networks

Relevant Topics